期刊文献+

黄连碱对L-NAME诱导高血压大鼠胸主动脉功能的影响 被引量:13

Effect of coptisine on the function of isolated thoracic aorta of L-NAME induced hypertensive rats
下载PDF
导出
摘要 目的探讨黄连碱对L-NAME致高血压大鼠胸主动脉舒缩功能的影响。方法采用NO合酶抑制剂L-NAME制备大鼠高血压模型,然后每天灌胃给予黄连碱低(10 mg.kg-1)、中(30 mg.kg-1)、高(100 mg.kg-1)3个剂量;给药干预6周后采用体外血管环活性评价方法,评价各组大鼠胸主动脉的收缩和舒张功能。结果 L-NAME诱导大鼠高血压模型,其胸主动脉的收缩和舒张功能均受到影响。给予黄连碱6周,黄连碱可明显增强L-NAME诱导高血压大鼠血管平滑肌对细胞内钙释放引起的收缩反应,并降低外钙内流引起的血管收缩能力,但对大鼠血压无影响,对血管的收缩功能和内皮依赖的舒张功能影响不大。结论 L-NAME制备大鼠高血压模型主要与NO的减少有关,而黄连碱可能影响IP3-Ca2+通路,对L-NAME诱导大鼠高血压没有降压作用。 Aim To investigate the effect of coptisine on the vascular activity of hypertensive rats treated by L-NAME.Methods Coptisine was orally administered for 6 weeks after the hypertension was established by L-NAME treatment in rats.Then the rat aorta was harvested to evaluate its vasoactivity induced by various stimulus.Results Chronic inhibition of nitric oxide synthesis by L-NAME led to sustained elevation of blood pressure of rats,as well as vascular dysfunction.Coptisine failed to block the increase of systolic blood pressure in the L-NAME treated rats without affecting the vasocontrictory profile and the endothelium-dependent vasorelaxation.However,the contraction induced by intracellular Ca^2+ released by the sarcoplasmic reticulum was enhanced by coptisine treatment,whereas the contractile response to CaCl2 in Ca^2+-free medium was decreased due to coptisine therapy.Conclusions These results indicate that the hypertension induced by L-NAME is associated with NO deficiency and coptisine might interfere with the IP3-Ca^2+ pathway in rat aortas.Coptisine shows no antihypertensive action on the L-NAME induced hypertensive rats.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第5期610-613,共4页 Chinese Pharmacological Bulletin
基金 重大新药创制科技重大专项(No2009ZX09302-003 2009ZX09501-021) 国家自然科学基金资助项目(No30572182)
关键词 黄连碱 高血压 胸主动脉 血管功能 L-NAME 一氧化氮 coptisine hypertension aorta vascular function L-NAME nitric oxide
  • 相关文献

参考文献2

二级参考文献22

  • 1王勇,倪柏锋,朱家新.复方黄连素注射液急性毒性试验[J].浙江畜牧兽医,2006,31(5):29-30. 被引量:1
  • 2王邦茂,翟春颖,方维丽,曹晓沧,姜葵,刘文天.黄连素对脱氧胆酸诱导的HT-29人结肠癌细胞增殖的抑制作用及机制研究[J].中华消化杂志,2006,26(11):749-752. 被引量:13
  • 3Couhas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development[ J]. Nature,2005,438(7070) :937 - 45.
  • 4Salvucci O, Yao L, Villalba S, et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1 [ J ]. Blood, 2002,99 ( 8 ) :2703 - 11.
  • 5Hong D, Triggle C R. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes : assessing the health of the endothelium [ J ]. Vascul Health Risk Manag,2005,1 ( 1 ) :55-71.
  • 6Hynynen M M, Raouf A. The vascular endothelin system in hypertension-recent patents and discoveries [ J ]. Recent Pat Cardiovasc Drug Discov ,2006 ,1 ( 1 ) :95 - 108.
  • 7Vanhoutte P M, Feletou M, Taddei S. Endothelium-dependent contractions in hypertension [ J ]. Br J Pharmacol, 2005,144 (4) : 449 - 58.
  • 8Limas C, Westrum B, Limas C J. The evolution of vascular changes in the spontaneously hypertensive rat [ J ]. Am J Pathol, 1980,98 (2) :357 -84.
  • 9Deanfield J E, Halcox J P, Rabelink T J. Endothelial function and dysfunction : testing and clinical relevance [ J ]. Circulation, 2007, 115 (10) : 1285 - 95.
  • 10Palmer R M, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor [J]. Nature,1987,327(6122) :524 -6.

共引文献135

同被引文献173

引证文献13

二级引证文献156

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部